Methanol extract of Evodia lepta displays Syk/Src-targeted anti-inflammatory activity

J Ethnopharmacol. 2013 Jul 30;148(3):999-1007. doi: 10.1016/j.jep.2013.05.030. Epub 2013 Jun 6.

Abstract

Ethnopharmacological relevance: Evodia lepta (Spreng.) Merr., in the Rutaceae family, is a medicinal plant traditionally used to treat inflammatory symptoms such as in meningitis and hepatitis. However, no study has systematically investigated its anti-inflammatory activities including its molecular mechanism.

Materials and methods: The effects of a methanol extract from the roots Evodia lepta (El-ME) were evaluated using lipopolysaccharide (LPS)-treated RAW264.7 cells producing nitric oxide (NO) and prostaglandin E2 (PGE2), and an HCl/ethanol-induced mouse gastritis model. Target molecules were identified by analyzing the activation of transcription factors and their upstream kinases.

Results: El-ME reduced the production of NO and PGE2 from LPS-activated RAW264.7 cells in a dose-dependent manner. El-ME also ameliorated the gastritis symptoms of EtOH/HCl-treated mice. The extract suppressed production of mRNA for the inducible NO synthase (iNOS) and cyclooxygenase (COX)-2; the nuclear translocation of nuclear factor (NF)-κB; the phosphorylation of upstream kinases that activate NF-κB; and the kinase activities of Syk and Src.

Conclusion: The anti-inflammatory effects of El-ME might be due to its suppression of Syk/Src and NF-κB. Considering the in vitro and in vivo efficacy of El-ME, Evodia lepta could be developed into an anti-inflammatory herbal remedy.

Keywords: (TNF)-α; 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Anti-inflammatory; CMC; COX; EIA; ELISA; Evodia lepta (Spreng.) Merr.; IκB kinase; IκBκ; Iκκ; LPS; MTT; NF-κB; NO; PG; PI3K; RT-PCR; Rutaceae; Src; Syk; TLR; Toll-like receptors (TLR); cyclooxygenase; enzyme immunoassay; enzyme-linked immunosorbent assay; iNOS; inducible NO synthase; inhibitor of kappa B alpha; lipopolysaccharide; nitric oxide; nuclear factor-κB; phosphoinositide 3-kinase; prostaglandin; reverse transcriptase-polymerase chain reaction; sodium carboxymethylcellulose; spleen tyrosine kinase; tumor necrosis factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Cell Line
  • Cell Survival / drug effects
  • Cells, Cultured
  • Dinoprostone / metabolism
  • Ethanol
  • Evodia*
  • Gastritis / chemically induced
  • Gastritis / drug therapy
  • Gastritis / pathology
  • HEK293 Cells
  • Humans
  • Hydrochloric Acid
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Male
  • Methanol / chemistry
  • Mice
  • Mice, Inbred ICR
  • NF-kappa B / metabolism
  • Nitric Oxide / metabolism
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Protein-Tyrosine Kinases / metabolism
  • Proto-Oncogene Proteins pp60(c-src) / metabolism
  • Solvents / chemistry
  • Stomach / pathology
  • Syk Kinase

Substances

  • Anti-Inflammatory Agents
  • Intracellular Signaling Peptides and Proteins
  • NF-kappa B
  • Plant Extracts
  • Solvents
  • Nitric Oxide
  • Ethanol
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins pp60(c-src)
  • SYK protein, human
  • Syk Kinase
  • Syk protein, mouse
  • Dinoprostone
  • Hydrochloric Acid
  • Methanol